Cargando…
Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition
Owing to the prevalence of tumor-associated macrophages (TAMs) in cancer and their unique influence upon disease progression and malignancy, macrophage-targeted interventions have attracted notable attention in cancer immunotherapy. However, tractable targets to reduce TAM activities remain very few...
Autores principales: | Giurisato, Emanuele, Xu, Qiuping, Lonardi, Silvia, Telfer, Brian, Russo, Ilaria, Pearson, Adam, Finegan, Katherine G., Wang, Wenbin, Wang, Jinhua, Gray, Nathanael S., Vermi, William, Xia, Zhengui, Tournier, Cathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866536/ https://www.ncbi.nlm.nih.gov/pubmed/29507229 http://dx.doi.org/10.1073/pnas.1707929115 |
Ejemplares similares
-
SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics
por: Boned del Río, Isabel, et al.
Publicado: (2019) -
Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence
por: Sang, Ben, et al.
Publicado: (2018) -
Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function
por: Rengachari, Srinivasan, et al.
Publicado: (2018) -
Self-Renewal of Macrophages: Tumor-Released Factors and Signaling Pathways
por: Filiberti, Serena, et al.
Publicado: (2022) -
Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G(1)–S Cell-Cycle Transition
por: Zhang, Jingwei, et al.
Publicado: (2022)